NYSE:ELOXSenesco Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Senesco Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.32 -0.01 (-0.30 %) (As of 08/14/2020 04:00 PM ET) Add Compare Share Today's Range$3.27Now: $3.32▼$3.3350-Day Range$2.73MA: $2.98▼$3.3452-Week Range$1.44Now: $3.32▼$8.16Volume2,724 shsAverage Volume148,558 shsMarket Capitalization$133.26 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesSocial Media Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Senesco Technologies. Previous Next 2.5 Community Rank Outperform VotesSenesco Technologies has received 25 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSenesco Technologies has received 25 “underperform” votes. (Add your “underperform” vote.)Community SentimentSenesco Technologies has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Senesco Technologies and other stocks. Vote “Outperform” if you believe ELOX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ELOX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSenesco Technologies does not currently pay a dividend.Dividend GrowthSenesco Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Senesco Technologies insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolNYSE:ELOX Previous Symbol CUSIPN/A CIKN/A Webwww.eloxxpharma.com Phone781-577-5300Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares40,138,000Market Cap$133.26 million Next Earnings Date11/3/2020 (Estimated) OptionableNot Optionable $3.32 -0.01 (-0.30 %) (As of 08/14/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ELOX News and Ratings via Email Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter. Senesco Technologies (NYSE:ELOX) Frequently Asked Questions How has Senesco Technologies' stock been impacted by Coronavirus? Senesco Technologies' stock was trading at $2.88 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ELOX stock has increased by 15.3% and is now trading at $3.32. View which stocks have been most impacted by COVID-19. When is Senesco Technologies' next earnings date? Senesco Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for Senesco Technologies. Has Senesco Technologies been receiving favorable news coverage? Media stories about ELOX stock have been trending neutral on Saturday, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Senesco Technologies earned a coverage optimism score of 0.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Senesco Technologies. Who are some of Senesco Technologies' key competitors? Some companies that are related to Senesco Technologies include Paradigm Biopharmaceuticals (PAR), Biotest (BIO), Inventiva (IVA), CEL-SCI (CVM), Pfenex (PFNX), Neptune Wellness Solutions (NEPT), IMV (IMV), TELIX Pharmaceutical (TLX), Starpharma (SPL), Silence Therapeutics (SLN), Synairgen (SNG), Ibio (IBIO), Verona Pharma (VRP), ProMetic Life Sciences (PLI) and Fennec Pharmaceuticals (FRX). View all competitors. What other stocks do shareholders of Senesco Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Senesco Technologies investors own include DURECT (DRRX), Achieve Life Sciences (ACHV), Aclaris Therapeutics (ACRS), AIM ImmunoTech (AIM), Aldeyra Therapeutics (ALDX), Accuray (ARAY), Assertio Therapeutics (ASRT), BioDelivery Sciences International (BDSI), Biocept (BIOC) and Canopy Growth (CGC). Who are Senesco Technologies' key executives? Senesco Technologies' management team includes the following people: Mr. Robert E. Ward, Chairman & CEO (Age 61)Dr. Silvia Noiman, Founder & Director (Age 62)Mr. Gregory L. Weaver CPA, M.B.A., Chief Financial Officer (Age 62)Dr. Gregory Williams, COO & Interim Chief Medical Officer (Age 59)Ms. Barbara Ryan, Investor Relations Officer What is Senesco Technologies' stock symbol? Senesco Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELOX." How do I buy shares of Senesco Technologies? Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Senesco Technologies' stock price today? One share of ELOX stock can currently be purchased for approximately $3.32. How big of a company is Senesco Technologies? Senesco Technologies has a market capitalization of $133.26 million. What is Senesco Technologies' official website? The official website for Senesco Technologies is www.eloxxpharma.com. How can I contact Senesco Technologies? The company can be reached via phone at 781-577-5300. This page was last updated on 8/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
